Navigation Links
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024
Date:9/1/2014

ting huge amount of money in biologics and it remains to be seen what proportion of this will be directed towards ADCs. The current market landscape will gradually evolve as large pharmaceutical companies look to gain competitive advantage in the ADC market. The future of the market is promising, though there are several challenges to meet.

SCOPE OF THE REPORT

The Antibody Drug Conjugates Market, 2014-2024 report provides an extensive study on this emerging field of therapeutics. The report covers various aspects, such as, advantages of antibody drug conjugates over traditional antibody therapeutics, the need for this new class of medicine, manufacturing challenges, key market drivers and upcoming opportunities.

One of the key objectives of this report is to understand the current and future state of the antibody drug conjugates market. This is done by analysing
- Products currently available in the market and those under development (both clinical / pre-clinical),
- Technology providers, and key cytotoxin, linker and conjugation technologies supporting the development of improved ADCs,
- Partnerships which have taken place over the last five years covering product co-development, technology licensing and co-marketing,
- Competitive landscape and inherent threats to growth in the short and long term,
- Development and sales potential based on target consumer segments, likely adoption rate and expected pricing.

The base year for the report is 2013; actual sales data has been presented for marketed ADCs during this year. The report provides short-mid term and long term market forecasts for the period 2014 - 2019 and 2019 - 2024, respectively. The research, analysis and insights presented in this report include potential sales of 11 marketed and pipeline ADCs; this analysis is backed by a deep understanding of key drivers behind the growth.

Owing to niche nature of the market, with most products in
'/>"/>

SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers
2. Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody for immunotherapy research
3. Telik Receives $1.5 Million National Cancer Institute Contract to Develop Novel Antibody-based PET Imaging Agent for Pancreatic Cancer
4. Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roches immunotherapy assay
5. Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody
6. FDA Grants Orphan Drug Designation for OncoSynergys Investigational Monoclonal Antibody OS2966 in the Treatment of Glioblastoma
7. EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma
8. Synthetic Biologics Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pertussis) at Gordon Research Conference
9. Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
10. arGEN-X Starts Phase Ib Expansion Cohorts With ARGX-110, a Novel Anti-CD70 Antibody, in Cancer Patients
11. BioLineRx and JHL Biotech to Collaborate on Type 1 Diabetes Antibody Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 2015 A global continuing medical ... and thyroid disorders in Central and South-East ... a major conference dedicated to these diseases. ... Online , Manage Hypertension Online and ... by EXCEMED - combine the world,s top ...
(Date:7/3/2015)... July 3, 2015 Un ... épidémies que sont l,hypertension, le diabète et les ... plateformes éducatives gratuites et d,une conférence majeure dédiée ... http://photos.prnewswire.com/prnh/20150630/227033 ) , Les formations ... , Prendre en charge l,hypertension en ligne ...
(Date:7/3/2015)... 3, 2015 Der ... bestimmter Abschlussbedingungen eine 100-prozentige Beteiligung am Unternehmen ... Mit dieser Übernahme dringt Lupin in den ... von 765 Mrd. RUB im Jahr 2014 ... gehörte (IMS Health). Seit über einem Jahrzehnt ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3
... PITTSBURGH, Oct. 13 BIOSAFE, Inc. , a ... has announced that they are launching in specific markets ... with BIOSAFE (®) . Crosstex, new BIOSAFE-treated Ultra ... VRE, and Staph immediately upon contact, and have further ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced ... 3,000,000 shares of its common stock at a price ... from the sale of shares in this offering, after ... expenses, were approximately $20.9 million. Sangamo intends to use ...
Cached Medicine Technology:BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 2BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 3BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza 4Sangamo Announces Closing of Common Stock Offering 2Sangamo Announces Closing of Common Stock Offering 3
(Date:7/5/2015)... MN (PRWEB) , ... July 06, 2015 , ... ... the ancillary benefits market, is excited to announce the next generation of PrimeStar ... and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and ...
(Date:7/5/2015)... Raleigh, NC (PRWEB) , ... July 05, 2015 , ... ... good data-gathering, a new IMRT/surgery combination may one day change the outlook for people ... to read it now. , Researchers report that five mesothelioma patients treated ...
(Date:7/4/2015)... , ... July 04, 2015 , ... ... solar industry’s leading recognition of technical sales expertise from the North American Board ... Sales ProfessionalTM. NABCEP is the most highly respected and well established national certification ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers believe ... asbestos exposure. Click here to read the complete story , just posted on ... Cedars Sinai Medical Center, and New York University exposed mice with a mutation on ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Smoothies are all ... a good blender and easily accessible, quality ingredients. Aurora Natural is proud to introduce ... an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering ...
Breaking Medicine News(10 mins):Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2
... /PRNewswire-FirstCall/ - MDS Nordion, a leading,provider of ... to their medical isotope customers about a ... from their primary supplier regarding,an interruption in ... manufacturing of,technetium-99m generators and iodine-131. The primary ...
... States,Golf Association (USGA) awarded a $20,000 matching grant to ... Program and the creation of a golf program at ... the USGA has supported programs that bring the game,of ... PGA Golf Pro,who leads the Winter Therapeutic Golf Clinics ...
... Nov. 30 Journalists from leading U.S.,news organizations ... organized by the,United Nations and the National Association ... on the impact of climate change, the fight ... the framework of the Millennium Development Goals (MDGs)., ...
... MD (November 30, 2007) Concerns over possible radiation effects ... New England Journal of Medicine should not scare people away ... a critical role in saving the lives of thousands of ... Association of Physicists in Medicine (AAPM). , In a statement ...
... a third, study found , , FRIDAY, Nov. 30 (HealthDay ... significantly slows the decline in lung function seen in ... team at Case Western Reserve University School of Medicine, ... took high doses of ibuprofen twice a day had ...
... Caraco Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) announced ... has granted tentative approval for the Company,s,Abbreviated New ... mg, 10 mg, and 20 mg., Escitalopram ... This tentative approval is for the generic bioequivalent ...
Cached Medicine News:Health News:MDS Nordion Provides Update to Medical Isotope Customers 2Health News:Marianjoy Rehabilitation Hospital Therapeutic Golf Program Receives a $20,000 Matching Grant From the USGA 2Health News:NABJ Joins with U.N. to Cover Climate Change and Development in Senegal 2Health News:NABJ Joins with U.N. to Cover Climate Change and Development in Senegal 3Health News:Hazards of CT scans overstated 2Health News:Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis 2Health News:Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R) 2
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
Use this workhorse apron where 360 of protection from direct and scatter radiation is required....
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
Medicine Products: